FAST NEWS: JW Therapeutics Announces Two Major Senior Appointments
The latest: Immunotherapy products maker JW (Cayman) Therapeutics Co. Ltd. (2126.HK) announced two major new appointments, including Dr. Shaun Paul Cordoba as its chief scientific officer and Raymond J. Hage…
RELATED ARTICLES
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK -
CARsgen seeks cell therapy breakthrough but stays in the red for now
2171.HK
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
- IPO pitch puts BrainAurora’s earnings under the microscope
- Cancer drug maker Genfleet joins Hong Kong IPO influx
